Stents, Bioresorbable

October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb bioresorbable vascular scaffold (BVS) is more cost effective and offers a higher quality of life than a best-in-class, permanent,...

Abbott announced positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and effectiveness of the dissolving Absorb heart device to Abbott's market-leading metallic XIENCE...

bioresorbable stents, dissolving stents

A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC) meetings is that bioresorbable stents will eventually replace conventional metallic stents...

bioresorbable stents
Ongoing clinical trials of bioresorbable stents continue to show positive data for the devices, which are widely expected to overtake metallic stents in the...
stents, bioresorbable, clinical trial, clinical study
Reva Medical initiated patient enrollment with its Fantom bioresorbable drug-eluting scaffold. 
Boston Scientific, EVOLVE II, Synergy, bioresorbable stent
In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific Synergy everolimus-eluting bioabsorbable polymer platinum...
Stentys, coronary stent, MiStent SES, Micell Technologies Inc.
Micell Technologies Inc. announced commercialization plans for its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent...
Micell Technologies Inc.'s thin-strut stent features elimination of the coating from the stent in 45-60 days and the complete absorption of

Articles

bioresorbable stents
Ongoing clinical trials of bioresorbable stents continue to show positive data for the devices, which are widely expected to overtake metallic stents in the...
October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb bioresorbable vascular scaffold (BVS) is...
ABSORB II Study DES Xience Abbot Vascular
Abbott announced positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and...
bioresorbable stents, dissolving stents, Absorb stent, BVS
A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and American College of Cardiology (ACC)...

Video Center

The America College of Cardiology has released its list of key late-breaking clinical trials at the...
1 week 18 hours ago
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict...
4 weeks 20 hours ago
There were a few intriguing technology trends at the Radiological Society of North America (RSNA)...
5 weeks 5 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...

Comparison Charts

Sorry there is no data available